SG Americas Securities’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,421
Closed -$12K 3350
2025
Q1
$12K Sell
1,421
-3,071
-68% -$47.4K ﹤0.01% 3408
2024
Q4
$161K Buy
4,492
+1,003
+29% +$51.9K ﹤0.01% 2351
2024
Q3
$165K Sell
3,489
-2,060
-37% -$90.9K ﹤0.01% 2641
2024
Q2
$279K Buy
5,549
+4,208
+314% +$304K ﹤0.01% 2000
2024
Q1
$150K Sell
1,341
-228
-15% -$22.7K ﹤0.01% 2206
2023
Q4
$91K Sell
1,569
-297
-16% -$11.9K ﹤0.01% 2797
2023
Q3
$59K Buy
+1,866
New +$88.7K ﹤0.01% 2902
2023
Q2
Sell
-1,864
Closed -$192K 2844
2023
Q1
$192K Sell
1,864
-93
-5% -$13.1K ﹤0.01% 2441
2022
Q4
$287K Buy
1,957
+373
+24% +$63K ﹤0.01% 1956
2022
Q3
$268K Sell
1,584
-318
-17% -$51.7K ﹤0.01% 2090
2022
Q2
$220K Buy
+1,902
New +$179K ﹤0.01% 2603
2022
Q1
Sell
-651
Closed -$101K 3277
2021
Q4
$101K Sell
651
-818
-56% -$159K ﹤0.01% 3083
2021
Q3
$346K Buy
+1,469
New +$429K ﹤0.01% 2813
2021
Q2
Sell
-500
Closed -$202K 3093
2021
Q1
$202K Buy
500
+229
+85% +$111K ﹤0.01% 2675
2020
Q4
$180K Sell
271
-1,133
-81% -$630K ﹤0.01% 2688
2020
Q3
$654K Buy
1,404
+726
+107% +$367K 0.01% 1460
2020
Q2
$397K Buy
678
+162
+31% +$55.3K ﹤0.01% 2292
2020
Q1
$75K Buy
+516
New +$90.2K ﹤0.01% 3087

Other funds holding MRSN